Literature DB >> 7949176

Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia.

G Pozzato1, C Mazzaro, M Crovatto, M L Modolo, S Ceselli, G Mazzi, S Sulfaro, F Franzin, P Tulissi, M Moretti.   

Abstract

Because a close relationship has been established between mixed cryoglobulinemia and hepatitis C virus (HCV) infection, the clinical, histologic, and virologic findings of 31 patients affected by mixed cryoglobulinemia have been determined. HCV infection was investigated by the presence of anti-HCV antibodies and by polymerase chain reaction (PCR) amplification of the 5' untranslated region (5'UTR), and the genotype of HCV was also determined according to Okamoto et al (J Gen Virol 73:673, 1992). A bone marrow (BM) biopsy was performed in all patients, and liver and kidney biopsies were performed when indicated. The prevalence of anti-HCV antibodies was high (83.9%); polymerase chain reaction amplification of the 5' untranslated region was positive in 26 subjects (83.9%), and Core region amplification in 26 of 27 subjects (96.2%). A high prevalence of genotype II was found (76.6%). Chronic liver disease was present in 15 (48%) patients. BM biopsy specimens showed the presence of low-grade non-Hodgkin's lymphomas in 12 cases (38.7%), whereas, in 11 patients (35.5%), the BM infiltration was not monoclonal (reactive). Mixed cryoglobulinemia is closely associated with HCV infection. Apparently, only 1 patient was not infected by the virus. Several HCV genotypes are involved in the pathogenesis of mixed cryoglobulinemia. The disease is associated with a high prevalence of low-grade non-Hodgkin's lymphomas.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7949176

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  50 in total

1.  Is hepatitis C virus a sialotropic virus?

Authors:  M Ramos-Casals; M Garcia-Carrasco; R Cervera; J Font
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

2.  Malignant lymphoma of the stomach after chemotherapy for hepatocellular carcinoma.

Authors:  I Matsuo; K Omagari; N Ikuno; H Kinoshita; Y Onizuka; M Itsuno; T Nakayama; S Kohno
Journal:  J Gastroenterol       Date:  1997-08       Impact factor: 7.527

3.  Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma.

Authors:  R Marasca; P Vaccari; M Luppi; P Zucchini; I Castelli; P Barozzi; A Cuoghi; G Torelli
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

Review 4.  Hepatitis viruses and non-Hodgkin's lymphoma: A review.

Authors:  Sibnarayan Datta; Soumya Chatterjee; Rudragoud S Policegoudra; Hemant K Gogoi; Lokendra Singh
Journal:  World J Virol       Date:  2012-12-12

Review 5.  Cryoglobulins and cryoglobulinemia. Diagnostic and therapeutic considerations.

Authors:  A Della Rossa; G Trevisani; S Bombardieri
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

6.  Hepatitis G virus infection in lymphoma and in blood donors.

Authors:  J Minton; A Iqbal; A Eskiturk; W Irving; J Davies
Journal:  J Clin Pathol       Date:  1998-09       Impact factor: 3.411

Review 7.  New and emerging infectious diseases.

Authors:  G L Mandell; G C Townsend
Journal:  Trans Am Clin Climatol Assoc       Date:  1998

8.  B cell non-Hodgkin's lymphoma in chronic hepatitis C virus patients: An interesting relationship.

Authors:  Hassan S Hamdy; Nadia A Abdelkader; Amal Mansour; Enas H Allam; Hisham M El-Wakiel; Dina Elshenawy
Journal:  Indian J Gastroenterol       Date:  2015-04-29

Review 9.  The hepatitis C virus persistence: how to evade the immune system?

Authors:  Nicole Pavio; Michael M C Lai
Journal:  J Biosci       Date:  2003-04       Impact factor: 1.826

10.  Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium.

Authors:  Silvia de Sanjose; Yolanda Benavente; Claire M Vajdic; Eric A Engels; Lindsay M Morton; Paige M Bracci; John J Spinelli; Tongzhang Zheng; Yawei Zhang; Silvia Franceschi; Renato Talamini; Elizabeth A Holly; Andrew E Grulich; James R Cerhan; Patricia Hartge; Wendy Cozen; Paolo Boffetta; Paul Brennan; Marc Maynadié; Pierluigi Cocco; Ramon Bosch; Lenka Foretova; Anthony Staines; Nikolaus Becker; Alexandra Nieters
Journal:  Clin Gastroenterol Hepatol       Date:  2008-04       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.